News &amp; Updates

Older adults are no strangers to malnutrition, which has been shown to be associated with chronic diseases and geriatric syndromes such as depression, frailty, sarcopenia, polypharmacy, cognitive impairment, and functional dependence, according to a study.

Malnutrition prevalence in older adults stresses need for early nutritional intervention

03 Jun 2026

Preliminary study shows potential of novel flow-diverting stent for aneurysms

The recently approved coated Derivo^® 2heal^® Embolization Device (DED 2H) appears promising for treating intracranial aneurysms, according to a preliminary study from Germany.

Preliminary study shows potential of novel flow-diverting stent for aneurysms

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

In breast cancer patients with obesity or type 2 diabetes (T2D), the use of a glucagon-like peptide-1 receptor agonist (GLP-1 RA) appears to exert favourable effects on mortality and recurrence, according to a retrospective study.

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

Newborns’ epigenetics and gut microbiome linked to later neurodevelopmental outcomes

Epigenetic patterns present at birth may shape how an infant’s gut microbiome develops in the first year of life, and both are associated with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) traits at the age of 3 years, researchers at the Chinese University of Hong Kong (CUHK) found.

Newborns’ epigenetics and gut microbiome linked to later neurodevelopmental outcomes

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Researchers from the Chinese University of Hong Kong (CUHK) and the Gerald Choa Neuroscience Institute (GCNI) have achieved a breakthrough “bench-to-bedside” advancement, translating discovery of multi-omic ageing counteraction with glucagon-like peptide-1 (GLP-1) receptor agonism into a potential new treatment strategy for stroke.

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Researchers from the University of Hong Kong (HKU) have developed the world’s first NanoPowder nasal spray for use as prehospital emergency treatment at the onset of an ischaemic stroke, which can potentially reduce brain damage by >80 percent and substantially increase stroke survival rates and neurological recovery, representing a significant advancement in stroke management globally.

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

Mainland China’s growing investment in medicine and biopharma is reshaping its research and healthcare landscape while creating new opportunities for Hong Kong – to contribute to, and benefit from – the next phase of development, noted Professor Chak-Sing Lau, Dean of Medicine, University of Hong Kong (HKU), at the 30^th Hong Kong Medical Forum

Mainland China’s healthcare surge and HK’s edge: A powerful synergy

Astegolimab gets mixed results in COPD

In the treatment of patients with chronic obstructive pulmonary disease (COPD), use of the anti-ST2 human IgG2 monoclonal antibody astegolimab every 2 weeks helps reduce the frequency of exacerbations compared with placebo in a phase 2b trial but not in a phase 3 trial.

Astegolimab gets mixed results in COPD

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

02 Jun 2026 by

Treatment with leflunomide in combination with hydroxychloroquine has been proven to be beneficial, helping reduce disease activity in patients with systemically active Sjögren’s disease, in the phase 2b RepurpSS-II trial.

Leflunomide–hydroxychloroquine’s efficacy in Sjögren’s disease confirmed in RepurpSS-II trial

Can HF patients with obesity undergo metabolic, bariatric procedures?

Undergoing metabolic and bariatric procedures (MBP) is feasible in some adults with obesity and heart failure (HF), according to a study.

Can HF patients with obesity undergo metabolic, bariatric procedures?